ロード中...
Synergy Between Two Chimeric Lysins to Kill Streptococcus pneumoniae
Phage lysins constitute a new generation of antimicrobials that are becoming a promising alternative and complementation to current antibiotic therapies, which are nowadays called into question by the increasing numbers of multiresistant bacteria. Streptococcus pneumoniae is a leading human pathogen...
保存先:
| 出版年: | Front Microbiol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6560164/ https://ncbi.nlm.nih.gov/pubmed/31231338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2019.01251 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|